Risultati di ricerca - Portale di modelli di dati medici (MDM-Portal)

GYNECOLOGIC ONCOLOGY GROUP Pathology Form - FORM F NCT00565851

- 26/06/15 - 1 modulo, 3 itemgroups, 31 elementi, 1 linguaggio

Itemgroups: Patient demographics, PRIMARY DISEASE ASSESSMENT, SECONDARY DISEASE ASSESSMENT

GYNECOLOGIC ONCOLOGY GROUP Pathology Form - FORM F NCT00565851 Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA4E8FA7-EE6F-210E-E034-0003BA12F5E7

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Pre-Treatment Summary Form - FORM DR

- 26/06/15 - 1 modulo, 4 itemgroups, 21 elementi, 1 linguaggio

Itemgroups: Patient demographics, NON-INVASIVE DIAGNOSTIC PROCEDURES, TUMOR EVALUATION, COMMENTS

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Pre-Treatment Summary Form - FORM DR Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA3F819F-A88A-3FEB-E034-0003BA12F5E7

GYNECOLOGIC ONCOLOGY GROUP Registration Form - FORM R NCT00565851

- 26/06/15 - 1 modulo, 4 itemgroups, 27 elementi, 1 linguaggio

Itemgroups: Patient demographics, TRACKING INFORMATION, DEMOGRAPHIC INFORMATION, COMMENTS

GYNECOLOGIC ONCOLOGY GROUP Registration Form - FORM R NCT00565851 Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA9EAD12-D5BB-0BD7-E034-0003BA12F5E7

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Recurrent Gynecologic Cancer - On Study Form - FORM OSR

- 26/06/15 - 1 modulo, 5 itemgroups, 36 elementi, 1 linguaggio

Itemgroups: Patient demographics, DISEASE DESCRIPTION - PRIOR HISTORY, DISEASE DESCRIPTION - CURRENT HISTORY, PRIOR TREATMENT FOR GYNECOLOGIC CANCER, COMMENTS

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Recurrent Gynecologic Cancer - On Study Form - FORM OSR Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA533423-E4AA-53B9-E034-0003BA12F5E7

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Solid Tumor Evaluation Form - FORM D2M

- 26/06/15 - 1 modulo, 6 itemgroups, 29 elementi, 1 linguaggio

Itemgroups: Patient demographics, TARGET LESION(S) EVALUATION, NON-TARGET LESION(S) EVALUATION, NEW TARGET LESION(S) AT FOLLOW-UP EVALUATION, OVERALL RESPONSE, Comments

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Solid Tumor Evaluation Form - FORM D2M Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA2BF104-B72B-1DC3-E034-0003BA12F5E7

Concomitant Medication Form, GOG-0212, Form CMED NCT00108745

- 16/06/15 - 1 modulo, 3 itemgroups, 20 elementi, 1 linguaggio

Itemgroups: HEADER MODULE, MEDICATION INFORMATION, COMMENT

Concomitant Medication Form, GOG-0212, Form CMED NCT00108745 Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FD45FED6-D996-72B6-E034-0003BA3F9857

GYNECOLOGIC ONCOLOGY GROUP Treatment Completion Form - FORM Q0 NCT00565851

- 03/06/15 - 1 modulo, 4 itemgroups, 19 elementi, 1 linguaggio

Itemgroups: Header module, TREATMENT SCHEDULE, OFF-TREATMENT REASON, Comments

GYNECOLOGIC ONCOLOGY GROUP Treatment Completion Form - FORM Q0 NCT00565851 Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA632D3C-41EC-2430-E034-0003BA12F5E7

Ovarian Cancer Registration SWOG S0904 NCT00872989 - Registration Worksheet Ovarian Cancer NCT00872989

- 20/05/15 - 1 modulo, 2 itemgroups, 6 elementi, 1 linguaggio

Itemgroups: SWOG Patient ID, Patient Information

Southwest Oncology Group S0904 Registration Worksheet for OPEN - Step 2 Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer NCT00872989 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7C965708-98F3-5904-E040-BB89AD432C8B

Ovarian Cancer NCT00993655 Off Treatment - NCIC OV 21 End of Treatment Form - 2874223v1.0 - NCIC OV 21 End of Treatment Form

- 09/01/15 - 1 modulo, 5 itemgroups, 22 elementi, 1 linguaggio

Itemgroups: Patient Information, OFF PROTOCOL THERAPY , CA 125 At the End of Protocol Treatment, Comments, Contact Information

NCIC OV 21 End of Treatment Form Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=69B8C40D-B831-E610-E040-BB89AD43211A

Ovarian Cancer NCT00993655 Follow-Up - NCIC OV 21 Follow-Up Report Form - 2874229v1.0 - NCIC OV 21 Follow-Up Report Form

- 09/01/15 - 1 modulo, 14 itemgroups, 60 elementi, 1 linguaggio

Itemgroups: Patient Information, TIMING OF REPORT, PHYSICAL EXAM, RESPONSE ASSESSMENT - QUESTION 2, TARGET LESIONS, NON-TARGET LESIONS DURING TREATMENT, NEW LESIONS, RADIOLOGY, CA 125 - TABLE, ADVERSE EVENTS / INTERCURRENT ILLNESS, ANTI-CANCER TREATMENT, QUALITY OF LIFE QUESTIONNAIRE, Comments, Contact Information

NCIC OV 21 Follow-Up Report Form Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=69B8C40D-B83D-E610-E040-BB89AD43211A

Fallopian Tube Cancer NCT01167712 On-Study - GOG-0262: Solid Tumor Evaluation Form (D2M version 3) - 2918350v1.0 - GOG-0262: Solid Tumor Evaluation Form (D2M version 3)

- 09/01/15 - 1 modulo, 6 itemgroups, 32 elementi, 1 linguaggio

Itemgroups: HEADER MODULE, TARGET LESION(S) EVALUATION, NON-TARGET LESION(S) EVALUATION, NEW LESION(S) AT FOLLOW-UP EVALUATION, Disease Status and Overall Best Response, Comments

GOG-0262: Solid Tumor Evaluation Form (D2M version 3) Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6E6221CA-7BE9-32FA-E040-BB89AD43071B

Fallopian Tube Cancer NCT00262847 Follow-Up - GOG-0218 Follow-Up Form - 2303387v3.0 - GOG-0218 Follow-Up Form

- 09/01/15 - 1 modulo, 10 itemgroups, 38 elementi, 1 linguaggio

Itemgroups: HEADER MODULE, VITAL STATUS, DISEASE FOLLOW-UP STATUS, NOTICE OF PROGRESSION/RECURRENCE, CA125 AND OTHER BIOMARKERS, NOTICE OF NEW PRIMARY, LATE ADVERSE EVENT, NON-PROTOCOL THERAPY, COMMENTS, FOOTER MODULE

GOG-0218 Follow-Up Form Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F0E07E6F-7EF7-42B7-E034-0003BA3F9857

Keywords

Sommario

Modelli di dati selezionati